Raia Drogasil S.A.
RADLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $33,224,152 | $52,647,030 | $40,563,922 | $42,506,067 |
| - Cash | $528,002 | $412,321 | $433,541 | $356,118 |
| + Debt | $7,695,215 | $7,067,464 | $6,057,912 | $5,178,120 |
| Enterprise Value | $40,391,365 | $59,302,173 | $46,188,293 | $47,328,069 |
| Revenue | $38,864,455 | $33,973,790 | $29,067,380 | $24,127,002 |
| % Growth | 14.4% | 16.9% | 20.5% | – |
| Gross Profit | $11,549,715 | $10,207,364 | $8,809,468 | $7,206,168 |
| % Margin | 29.7% | 30% | 30.3% | 29.9% |
| EBITDA | $3,140,395 | $2,752,170 | $2,452,598 | $2,630,375 |
| % Margin | 8.1% | 8.1% | 8.4% | 10.9% |
| Net Income | $1,197,694 | $1,054,973 | $996,112 | $751,934 |
| % Margin | 3.1% | 3.1% | 3.4% | 3.1% |
| EPS Diluted | 0.72 | 0.62 | 0.58 | 0.44 |
| % Growth | 16.1% | 6.9% | 31.8% | – |
| Operating Cash Flow | $1,912,580 | $962,539 | $1,682,255 | $1,550,545 |
| Capital Expenditures | -$1,283,653 | -$1,304,581 | -$1,188,782 | -$855,596 |
| Free Cash Flow | $628,927 | -$342,042 | $493,473 | $694,949 |